News

By Priscila Mayumi Kashiwabara

Personalised medicine in Brazil: IP and regulatory challenges

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara authored the chapter "Personalised medicine in Brazil: IP and regulatory challenges". This article first appeared in IAM Life Sciences: Key issues for senior life sciences executives 2021, a supplement to IAM, published by Law Business Research – IP Division.
 
Click below to access the full chapter.
Back

Last by Priscila Mayumi Kashiwabara

June 8, 2022

INPI publishes communication on new sequence listing standard for patent applications in Brazil

On 7 June 2022, in the Official Gazette 2683, the Brazilian patent office published a communication regarding the new standard for submission INPI publishes communication on new sequence listing standard for patent applications in Brazil

Ler notícia

March 28, 2022

Brazilian PTOs publishes a technical note providing guidance on the patentability of elite events

On March 17, 2022, the BPTO released the INPI/CPAPD technical note No. 01/2022, which provides guidance on the patentability of inventions involving Brazilian PTOs publishes a technical note providing guidance on the patentability of elite events

Ler notícia

February 14, 2022

Life sciences patent eligibility in Latin America: a guide

Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that Life sciences patent eligibility in Latin America: a guide

Ler notícia